Search research articles
Contact Us
Filters
Showing results (121-130 of 182) with videos related to
Page
of 19
Sort By:
Cancer Investigation
|
February 10, 2006
A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract
Brian G Czito, Timothy J Hong, Darrel P Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2007
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma
Brian G Czito, Chris R Kelsey, Herbert I Hurwitz, et al.
IRB
|
June 26, 2009
An intervention to improve cancer patients' understanding of early-phase clinical trials
Nancy E Kass, Jeremy Sugarman, Amy M Medley, et al.
Cancer Chemotherapy and Pharmacology
|
February 27, 2017
Phase I study of pazopanib plus TH-302 in advanced solid tumors
Richard F Riedel, Kellen L Meadows, Paula H Lee, et al.
Journal of Neuroendocrinology
|
February 11, 2025
Phase Ib/II study of Pembrolizumab with Lanreotide depot for advanced, progressive Gastroenteropancreatic neuroendocrine tumors (PLANET)
Michael A Morse, Erika J Crosby, Daniel M Halperin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2020
Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
Xiaoju Max Ma, Johanna C Bendell, Herbert I Hurwitz, et al.
BMC Cancer
|
May 18, 2013
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors
Lee S Rosen, Lara Lipton, Timothy J Price, et al.
Cancer Medicine
|
August 10, 2013
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
Hope E Uronis, Stephanie M Cushman, Johanna C Bendell, et al.
Cancer Chemotherapy and Pharmacology
|
June 30, 2012
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
John H Strickler, Alexander N Starodub, Jingquan Jia, et al.
The Oncologist
|
December 16, 2018
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Herbert I Hurwitz, Benjamin R Tan, James A Reeves, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 182) with videos related to
Sort By:
Page
of 19
Cancer Investigation
|
February 10, 2006
A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract
Brian G Czito, Timothy J Hong, Darrel P Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2007
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma
Brian G Czito, Chris R Kelsey, Herbert I Hurwitz, et al.
IRB
|
June 26, 2009
An intervention to improve cancer patients' understanding of early-phase clinical trials
Nancy E Kass, Jeremy Sugarman, Amy M Medley, et al.
Cancer Chemotherapy and Pharmacology
|
February 27, 2017
Phase I study of pazopanib plus TH-302 in advanced solid tumors
Richard F Riedel, Kellen L Meadows, Paula H Lee, et al.
Journal of Neuroendocrinology
|
February 11, 2025
Phase Ib/II study of Pembrolizumab with Lanreotide depot for advanced, progressive Gastroenteropancreatic neuroendocrine tumors (PLANET)
Michael A Morse, Erika J Crosby, Daniel M Halperin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2020
Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
Xiaoju Max Ma, Johanna C Bendell, Herbert I Hurwitz, et al.
BMC Cancer
|
May 18, 2013
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors
Lee S Rosen, Lara Lipton, Timothy J Price, et al.
Cancer Medicine
|
August 10, 2013
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
Hope E Uronis, Stephanie M Cushman, Johanna C Bendell, et al.
Cancer Chemotherapy and Pharmacology
|
June 30, 2012
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
John H Strickler, Alexander N Starodub, Jingquan Jia, et al.
The Oncologist
|
December 16, 2018
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Herbert I Hurwitz, Benjamin R Tan, James A Reeves, et al.
Page
of 19